Submit Manuscript  

Article Details


Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial

[ Vol. 17 , Issue. 2 ]

Author(s):

Eman M. Ibrahem*, Salwa S. El-gendi, Amal A. Mahmoud, Sherif M. Abdel-Aal, Fatma H. El Nouby and Hanan Sharaf El-Deen Mohammed   Pages 258 - 266 ( 9 )

Abstract:


Objective: This is a secondary analysis of a randomized controlled trial that aimed to assess subclinical atherosclerosis in patients with rheumatoid arthritis (RA) by measuring carotid artery intima-media thickness (CIMT) and correlating it with disease activity and inflammatory markers (including levels of matrix metalloproteinase-3(MMP-3) and matrix metalloproteinase-9 (MMP-9)) and to detect the effectiveness of agents that inhibit matrix metalloproteinases (MMPs) as doxycycline in RA therapy.

Methods: One hundred and sixty RA patients were assigned in a randomized clinical trial (clinicaltrial. gov NCT03194204). Disease activity score 28(DAS28), laboratory markers, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), MMP-3, and MMP-9 were evaluated and mean CIMT was measured. Subjects were allocated randomly into one of two treatment arms, either methotrexate (MTX) alone or MTX with doxycycline 200mg per day orally. Follow up ESR, CRP, DAS28, MMP-3, and MMP-9 levels were re-evaluated after 3 months.

Results: There were positive significant correlations between CIMT and disease duration (r = 0.461, p = 0.001), age (r=0.459, p= 0.001), DAS28 score (r= 0.547, p = 0.001), ESR (r =0.413, p = 0.001), CRP (r = 0.281, p = 0.001), MMP-3 (r = 0.476, p = 0.001), and MMP-9 (r = 0.593, p =0.001). Patients treated with MTX and doxycycline showed lower levels of DAS28, ESR, CRP, MMP-3, and MMP-9 and this was statistically significant.

Conclusion: CIMT seems to be the ultimate method to screen for subclinical atherosclerosis in RA patients. MMP-3 and 9 play a key role in both RA synovitis and cardiovascular changes, making them important therapeutic targets, especially with safe and cost-effective agents like doxycycline. This clinical trial was carried out in Assiut University Hospital (AUH), Assiut, Egypt (Clinical Trial Registration No. clinicaltrial.gov NCT03194204).

Keywords:

Rheumatoid arthritis, matrix metalloproteinases, atherosclerosis, randomized clinical trial, combination therapy, CIMT.

Affiliation:

Internal Medicine Department, Faculty of Medicine, Assiut University, Assiut, Internal Medicine Department, Faculty of Medicine, Assiut University, Assiut, Clinical Pathology Department, Faculty of Medicine, Assiut University, Assiut, Diagnostic Radiology Department, Faculty of Medicine, Assiut University, Assiut, Rehabilitation and Rheumatology Department, Faculty of Medicine, Aswan University, Aswan, Internal Medicine Department, Faculty of Medicine, Assiut University, Assiut

Graphical Abstract:



Read Full-Text article